Reaction

Scleritis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,576 reports · 66 co-occurring drugs

As of the last recalculation, Scleritis appears in 1,576 FAERS reports alongside 66 co-occurring drug terms. The strongest observed disproportionality signal is METHYLPREDNISOLONE ACETATE (PRR 135.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Methylprednisolone Acetate	78	135.3	136.6
Trimethoprim	49	56.6	56.9
Tofacitinib Citrate	51	53.1	53.3
Amitriptyline Hydrochloride	45	34.8	34.9
Prednisolone Acetate	26	33.7	33.8
Adalimumab-Fkjp	107	32.7	32.7
Adalimumab-Aaty	106	31.6	31.7
Esomeprazole Magnesium Capsule, Delayed Release	34	31.6	31.7
Esomeprazole Magnesium Delayed Release Capsules	34	31.6	31.7
Esomeprazole Magnesium Dihydrate	34	31.5	31.5
Adalimumab-Adaz	112	30.1	30.2
Azathioprine	154	25.5	25.5
Atropine Sulfate	20	24.8	24.8
Naproxen Sodium Tablet, Coated	23	22.7	22.8
Naproxen Sodium, Coated Tablets	23	22.7	22.8
Naproxen Sodium 220Mg	23	22.7	22.8
Zoledronic Acid	61	20.8	20.9
Sulfasalazine	109	19.7	19.7
Meloxicam	76	18.1	18.1
Faricimab	11	18.0	18.1
Atropine	10	16.0	16.1
Alendronate Sodium	114	16.0	16.0
Hydrocortisone Sodium Succinate	11	15.6	15.6
Triamcinolone Acetonide Ointment Usp, 0.05%	27	15.5	15.5
Dicyclomine Hydrochloride	16	15.0	15.0
Risedronate Sodium	34	14.7	14.8
Methylprednisolone Sodium Succinate	50	14.7	14.7
Moxifloxacin	15	14.2	14.2
Naproxen	79	13.9	13.9
Dexlansoprazole	42	13.6	13.6
Hydroxychloroquine Sulfate	88	13.5	13.5
Pantoprazole Sodium In 0.9% Sodium Chloride	59	13.0	13.0
Pantoprazole Sodium Injection	59	13.0	13.0
Tocilizumab	105	12.9	13.0
Moxifloxacin Hydrochloride	19	12.5	12.5
Oxycodone And Acetaminophen Tablets	11	12.3	12.3
Triamcinolone Acetonide	28	12.2	12.2
Golimumab	74	11.9	11.9
Cortisone Acetate	11	11.8	11.9
Dexamethasone Sodium Phosphate	9	11.8	11.8
Sulfamethoxazole And Trimethoprim	72	11.8	11.8
Alendronate Sodium Tablet	16	11.5	11.5
Methotrexate Sodium	340	11.5	11.5
Methotrexate	298	11.3	11.3
Esomeprazole	50	11.0	11.0
Infliximab	161	10.7	10.7
Tofacitinib	134	10.4	10.4
Hydroxychloroquine	53	9.7	9.7
Amphotericin B	9	9.5	9.5
Diclofenac Potassium, Film Coated	6	9.4	9.5
Diclofenac Potassium Tablets	6	9.4	9.4
Aflibercept	21	9.0	9.0
Rituximab	132	8.9	8.9
Anakinra	10	8.0	8.0
Ranitidine Hydrochloride	30	7.4	7.4
Diclofenac Potassium	6	7.4	7.4
Certolizumab Pegol	63	7.4	7.4
Adalimumab	317	7.2	7.2
Abatacept	71	7.0	7.0
Oxycodone And Acetaminophen	11	6.3	6.3
Etanercept	238	6.0	6.0
Crizotinib	5	5.2	5.2
Ranitidine	74	5.1	5.1
Pseudoephedrine Hcl	4	4.8	4.8
Pseudoephedrine Hydrochloride	3	3.9	3.9
Guselkumab	6	2.2	2.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.